We are pleased to announced that Neurinnov contributes to the DREIMS european project under the program HORIZON EIC-2023-TRANSITION.
Il will last 36 months and intends to design and develop a multi-contact neural stimulator based on our selective neural stimulation technology in order to treat spinal cord injury, by combining biomaterials, pharmaceuticals, and electrical stimulation into an innovative therapeutic solution able to promote the closure of the spinal cord gap, with axonal regrowth and glial cell migration across large lesions in rodent and porcine models of spinal cord injury.
You can visit DREIMS’ web site at: http://www.dreims-project.eu